Sweilem B. Al Rihani

1.1k total citations
18 papers, 695 citations indexed

About

Sweilem B. Al Rihani is a scholar working on Pharmacology, Physiology and Geriatrics and Gerontology. According to data from OpenAlex, Sweilem B. Al Rihani has authored 18 papers receiving a total of 695 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 5 papers in Physiology and 4 papers in Geriatrics and Gerontology. Recurrent topics in Sweilem B. Al Rihani's work include Alzheimer's disease research and treatments (4 papers), Pharmaceutical Practices and Patient Outcomes (4 papers) and Drug Transport and Resistance Mechanisms (3 papers). Sweilem B. Al Rihani is often cited by papers focused on Alzheimer's disease research and treatments (4 papers), Pharmaceutical Practices and Patient Outcomes (4 papers) and Drug Transport and Resistance Mechanisms (3 papers). Sweilem B. Al Rihani collaborates with scholars based in United States, Canada and Jordan. Sweilem B. Al Rihani's co-authors include Lucy I. Darakjian, Jacques Turgeon, Véronique Michaud, Malavika Deodhar, Amal Kaddoumi, Pamela Dow, Meghan J. Arwood, Yazan S. Batarseh, Loqman A. Mohamed and Khalid A. El Sayed and has published in prestigious journals such as International Journal of Molecular Sciences, Neuroscience and Critical Care Medicine.

In The Last Decade

Sweilem B. Al Rihani

17 papers receiving 679 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sweilem B. Al Rihani United States 13 200 126 109 99 81 18 695
Eunhee Ji South Korea 17 314 1.6× 81 0.6× 95 0.9× 160 1.6× 131 1.6× 58 1.2k
Manuel Ibarra Uruguay 15 239 1.2× 66 0.5× 133 1.2× 77 0.8× 70 0.9× 58 968
Pengqian Wang China 20 395 2.0× 62 0.5× 109 1.0× 162 1.6× 217 2.7× 71 1.2k
Mahaveer Golechha India 17 218 1.1× 102 0.8× 97 0.9× 111 1.1× 172 2.1× 32 910
Alexandra Maier‐Salamon Austria 17 238 1.2× 219 1.7× 84 0.8× 86 0.9× 92 1.1× 31 796
Sumit Sharma India 17 327 1.6× 110 0.9× 54 0.5× 95 1.0× 220 2.7× 22 964
Barbara Schug Germany 16 151 0.8× 73 0.6× 59 0.5× 99 1.0× 112 1.4× 47 991
Wan Gyoon Shin South Korea 20 211 1.1× 118 0.9× 115 1.1× 118 1.2× 188 2.3× 62 1.2k
Weihong Ge China 16 274 1.4× 84 0.7× 96 0.9× 60 0.6× 185 2.3× 58 817
Peter Dogterom Netherlands 18 206 1.0× 76 0.6× 48 0.4× 145 1.5× 153 1.9× 41 896

Countries citing papers authored by Sweilem B. Al Rihani

Since Specialization
Citations

This map shows the geographic impact of Sweilem B. Al Rihani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sweilem B. Al Rihani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sweilem B. Al Rihani more than expected).

Fields of papers citing papers by Sweilem B. Al Rihani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sweilem B. Al Rihani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sweilem B. Al Rihani. The network helps show where Sweilem B. Al Rihani may publish in the future.

Co-authorship network of co-authors of Sweilem B. Al Rihani

This figure shows the co-authorship network connecting the top 25 collaborators of Sweilem B. Al Rihani. A scholar is included among the top collaborators of Sweilem B. Al Rihani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sweilem B. Al Rihani. Sweilem B. Al Rihani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Rihani, Sweilem B. Al, Hassan Y. Ebrahim, Nour F. Al-Ghraiybah, et al.. (2024). The Usnic Acid Analogue 4-FPBUA Enhances the Blood–Brain Barrier Function and Induces Autophagy in Alzheimer’s Disease Mouse Models. ACS Chemical Neuroscience. 15(17). 3152–3167. 2 indexed citations
2.
Rihani, Sweilem B. Al, et al.. (2022). Pharmacist‐driven interventions to de‐escalate urinary antimuscarinics in the Programs of All‐Inclusive Care for the Elderly. Journal of the American Geriatrics Society. 70(11). 3230–3238. 6 indexed citations
3.
Deodhar, Malavika, Sweilem B. Al Rihani, Lucy I. Darakjian, Jacques Turgeon, & Véronique Michaud. (2021). Assessing the Mechanism of Fluoxetine-Mediated CYP2D6 Inhibition. Pharmaceutics. 13(2). 148–148. 47 indexed citations
4.
Rihani, Sweilem B. Al, Malavika Deodhar, Lucy I. Darakjian, et al.. (2021). Quantifying Anticholinergic Burden and Sedative Load in Older Adults with Polypharmacy: A Systematic Review of Risk Scales and Models. Drugs & Aging. 38(11). 977–994. 41 indexed citations
5.
Rihani, Sweilem B. Al, Lucy I. Darakjian, Malavika Deodhar, et al.. (2021). Disease-Induced Modulation of Drug Transporters at the Blood–Brain Barrier Level. International Journal of Molecular Sciences. 22(7). 3742–3742. 35 indexed citations
6.
7.
Wani, Abubakar, Sweilem B. Al Rihani, Ankita Sharma, et al.. (2021). Crocetin promotes clearance of amyloid-β by inducing autophagy via the STK11/LKB1-mediated AMPK pathway. Autophagy. 17(11). 3813–3832. 106 indexed citations
8.
Michaud, Véronique, Pamela Dow, Sweilem B. Al Rihani, et al.. (2020). Risk Assessment of Drug‐Induced Long QT Syndrome for Some COVID‐19 Repurposed Drugs. Clinical and Translational Science. 14(1). 20–28. 36 indexed citations
9.
Michaud, Véronique, Malavika Deodhar, Meghan J. Arwood, et al.. (2020). ACE2 as a Therapeutic Target for COVID-19; Its Role in Infectious Processes and Regulation by Modulators of the RAAS System. Journal of Clinical Medicine. 9(7). 2096–2096. 28 indexed citations
10.
Deodhar, Malavika, Sweilem B. Al Rihani, Meghan J. Arwood, et al.. (2020). Mechanisms of CYP450 Inhibition: Understanding Drug-Drug Interactions Due to Mechanism-Based Inhibition in Clinical Practice. Pharmaceutics. 12(9). 846–846. 140 indexed citations
11.
Rihani, Sweilem B. Al, et al.. (2020). Risk of Adverse Drug Events Following the Virtual Addition of COVID-19 Repurposed Drugs to Drug Regimens of Frail Older Adults with Polypharmacy. Journal of Clinical Medicine. 9(8). 2591–2591. 14 indexed citations
12.
Rihani, Sweilem B. Al, Lucy I. Darakjian, & Amal Kaddoumi. (2019). Oleocanthal-Rich Extra-Virgin Olive Oil Restores the Blood–Brain Barrier Function through NLRP3 Inflammasome Inhibition Simultaneously with Autophagy Induction in TgSwDI Mice. ACS Chemical Neuroscience. 10(8). 3543–3554. 56 indexed citations
13.
Rihani, Sweilem B. Al, Renny S. Lan, & Amal Kaddoumi. (2019). Granisetron Alleviates Alzheimer’s Disease Pathology in TgSwDI Mice Through Calmodulin-Dependent Protein Kinase II/cAMP-Response Element Binding Protein Pathway. Journal of Alzheimer s Disease. 72(4). 1097–1117. 8 indexed citations
14.
Wang, Yi‐Jun, Yunkai Zhang, Guan-Nan Zhang, et al.. (2017). Regorafenib overcomes chemotherapeutic multidrug resistance mediated by ABCB1 transporter in colorectal cancer: In vitro and in vivo study. Cancer Letters. 396. 145–154. 64 indexed citations
15.
Batarseh, Yazan S., Loqman A. Mohamed, Sweilem B. Al Rihani, et al.. (2017). Oleocanthal ameliorates amyloid-β oligomers’ toxicity on astrocytes and neuronal cells: In vitro studies. Neuroscience. 352. 204–215. 51 indexed citations
16.
Qosa, Hisham, Loqman A. Mohamed, Sweilem B. Al Rihani, et al.. (2016). High-Throughput Screening for Identification of Blood-Brain Barrier Integrity Enhancers: A Drug Repurposing Opportunity to Rectify Vascular Amyloid Toxicity. Journal of Alzheimer s Disease. 53(4). 1499–1516. 45 indexed citations
17.
18.
Nazer, Lama, Sweilem B. Al Rihani, Feras Hawari, & Jennifer Lê. (2013). 907. Critical Care Medicine. 41. A227–A227.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eunhee Ji Breakdown of academic impact, for papers by Manuel Ibarra Breakdown of academic impact, for papers by Pengqian Wang Breakdown of academic impact, for papers by Mahaveer Golechha Breakdown of academic impact, for papers by Alexandra Maier‐Salamon Breakdown of academic impact, for papers by Sumit Sharma Breakdown of academic impact, for papers by Barbara Schug Breakdown of academic impact, for papers by Wan Gyoon Shin Breakdown of academic impact, for papers by Weihong Ge Breakdown of academic impact, for papers by Peter Dogterom
Rankless by CCL
2026